• Explore /
  • Poster
  • / Association of TMB and PD-L1 with efficacy of first-line pembrolizumab (pembro) or pembro + chemotherapy (chemo) versus chemo in patients (pts) with advanced urothelial carcinoma (UC) from KEYNOTE-361.

Association of TMB and PD-L1 with efficacy of first-line pembrolizumab (pembro) or pembro + chemotherapy (chemo) versus chemo in patients (pts) with advanced urothelial carcinoma (UC) from KEYNOTE-361.

Abstract Video & Slides Poster

Authors

Rafael Morales-Barrera, Sr

Rafael Morales-Barrera

Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Rafael Morales-Barrera , Thomas Powles , Mustafa Ozguroglu , Tibor Csoszi , Yohann Loriot , Aude Flechon , Nobuaki Matsubara , Alejo Rodriguez-Vida , Lajos Geczi , Susanna Y. Cheng , Yves Fradet , Stephane Oudard , Seyda Gunduz , Junshui Ma , Mohini Rajasagi , Amir Vajdi , Razvan Cristescu , Kentaro Imai , Blanca Homet Moreno , Ajjai Shivaram Alva

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02853305

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 540)

DOI

10.1200/JCO.2022.40.6_suppl.540

Abstract #

540

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Zev A. Wainberg

First Author: Kohei Shitara

First Author: Lin Shen

First Author: Sun Young Rha